A case of M2a with complex chromosome aberrations obtained complete remission through modified As2O3 medication.
Zhou
Jin
J
Department of Hematology, First Clinical College of Harbin Medical University, Harbin 15001. jinzhou@lycos.com
Meng
Ran
R
Zhao
Da-Ya
DY
Yang
Bao-Feng
BF
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage / Q000627:therapeutic use*; D002869:Chromosome Aberrations; D006801:Humans; D007262:Infusions, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D010087:Oxides / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide